Loading clinical trials...
Loading clinical trials...
A Multi-Reader Multi-Case (MRMC) Study Assessing the Impact of Legit.Health Plus on the Diagnostic Accuracy and Referral Decision-Making of Primary Care Physicians for Skin Lesions.
Conditions
Interventions
AI-based medical device for aided diagnosis in dermatological conditions
Locations
1
Spain
AI Labs Group S.L.
Bilbao, Basque Country, Spain
Start Date
June 4, 2024
Primary Completion Date
September 13, 2024
Completion Date
September 13, 2024
Last Updated
February 24, 2026
NCT07287917
NCT06545682
NCT06605443
NCT06934759
NCT02956265
NCT07429123
Lead Sponsor
AI Labs Group S.L
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions